Abstract
Swedish laboratories reported an increase of Mycoplasma pneumoniae during the autumn 2011. Data from the laboratory in Skövde, covering 12.9% of the Swedish population, indicate an approximate increase in the number of laboratory-confirmed cases in the whole country, from around 3,500 in 2009 to 11,100 in 2011. Antibiotics are recommended only for pneumonia, not bronchitis, but compared with the autumn 2009, 42,652 more prescriptions of doxycycline and macrolides were registered in the autumn 2011.
Highlights
Mycoplasma pneumoniae infections are not reportable in Sweden, but in the autumn 2010, the Swedish Institute for Communicable Disease Control (SMI) received informal information from several laboratories that the number of laboratory-confirmed diagnoses of M. pneumoniae had increased, and in 2011 an even greater increase was noted
We use the data from Skövde as a proxy to analyse the epidemic in Sweden as a whole
The number of samples examined by polymerase chain reaction (PCR) for pathogens causing cough between 2002 and 2011 varied from 350 to 3,000 per year, with the highest level in 2011
Summary
The laboratory in Skövde covers 12.9% of the Swedish population It has collected data from 2002 to 2011 on polymerase chain reaction (PCR) results and the total number of examined samples for bacteria causing protracted cough: M. pneumoniae, Chlamydophila pneumoniae and Bordetella pertussis/parapertussis. It has collected data on M. pneumoniae IgM serology since 2006. Sampling of these cough pathogens was performed only for clinical purposes and the number of collected samples reflect provisional diagnoses or suspicions of the clinical doctor. We use the data from Skövde as a proxy to analyse the epidemic in Sweden as a whole
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
